LILAC - Anifrolumab in DLR
Clinical Trial Grant
Administered By
Medicine, Rheumatology and Immunology
Awarded By
AstraZeneca Pharmaceuticals, LP
Start Date
October 17, 2025
End Date
October 31, 2027
Administered By
Medicine, Rheumatology and Immunology
Awarded By
AstraZeneca Pharmaceuticals, LP
Start Date
October 17, 2025
End Date
October 31, 2027